BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
5.00
-0.22 (-4.21%)
Sep 18, 2025, 11:46 AM EDT
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $87.32 million as of September 18, 2025. Its market cap has decreased by -51.50% in one year.
Market Cap
87.32M
Enterprise Value
60.07M
Revenue
307.26M
Ranking
n/a
PE Ratio
4.59
Stock Price
$5.00
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 87.32M, an increase of 1,728.98%. That is a compound annual growth rate of 19.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 87.32M | -62.11% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | 13.30M | -41.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |